Background The therapeutic potential of mesenchymal stromal cells (MSCs) may be largely
mediated by paracrine factors contained in microvesicles (MV) released from intracellular …

INTRODUCTION: The incidence of symptomatic catheter-related deep vein thrombosis (DVT)
in cancer patients remains unclear and there is a lack of reliable data on the risk factors of …

Autologous hematopoietic cell transplantation (AHCT) as initial therapy of patients with
multiple myeloma (MM) improves survival. However, data to support this approach for relapsed/…

Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic strategy …

Environmental drivers of coral condition (maximum quantum yield, symbiont density,
chlorophyll a content and coral skeletal growth rates) were assessed in the equatorial inshore …

Importance Some patients with myasthenia gravis (MG) do not respond to conventional
treatment and have severe or life-threatening symptoms. Alternate and emerging therapies have …

Chronic graft-versus-host disease (cGVHD) remains one of the most significant long-term
complications after allogeneic blood and marrow transplantation. Diagnostic biomarkers for …

Background Hematopoietic Stem cell Transplantation (HSCT) can negatively impact the
psychosocial well-being of the patient. Social support is a complex term that has been variably …

Autologous hematopoietic cell transplantation (AHCT) for plasma cell myeloma is performed
less often in people >70 years old than in people ≤70 years old. We analyzed 11,430 …

Background Upfront autologous hematopoietic stem cell transplantation (AHCT) remains an
important therapy in the management of patients with multiple myeloma (MM), a disease of …